Ison, P J <br/><br/>
Neurotransmitter receptor binding studies predict antiemetic efficacy and side effects.  [electronic resource] 

 -  Cancer treatment reports  May 1986 
 - 637-41 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0361-5960 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiemetics--metabolism<br/>Biotransformation<br/>Brain Chemistry<br/>Caudate Nucleus--metabolism<br/>Cerebral Cortex--metabolism<br/>Chlorpromazine--metabolism<br/>In Vitro Techniques<br/>Prochlorperazine--metabolism<br/>Radioligand Assay<br/>Rats<br/>Receptors, Adrenergic, alpha--metabolism<br/>Receptors, Dopamine--metabolism<br/>Receptors, Dopamine D2<br/>Receptors, Neurotransmitter--antagonists & inhibitors